Attard, G;
Brown, LC;
Clarke, NW;
Parmar, MKB;
James, ND;
(2021)
Should Patients with High-risk Localised or Locally Advanced Prostate Cancer Receive Abiraterone Acetate in Addition to Androgen Deprivation Therapy? Update on a Planned Analysis of the STAMPEDE Trial.
European Urology
, 80
(4)
pp. 522-523.
10.1016/j.eururo.2021.06.023.
Preview |
Text
Brown_EURUROL-S-21-01120.pdf - Accepted Version Download (492kB) | Preview |
Archive Staff Only
View Item |